Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs BERYL DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA BERYL DRUGS GSK PHARMA/
BERYL DRUGS
 
P/E (TTM) x 62.2 12.6 493.7% View Chart
P/BV x 18.9 1.8 1,024.1% View Chart
Dividend Yield % 1.6 0.0 -  

Financials

 GSK PHARMA   BERYL DRUGS
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
BERYL DRUGS
Mar-23
GSK PHARMA/
BERYL DRUGS
5-Yr Chart
Click to enlarge
High Rs1,68418 9,353.9%   
Low Rs1,2318 16,409.3%   
Sales per share (Unadj.) Rs191.953.0 361.9%  
Earnings per share (Unadj.) Rs35.91.5 2,374.0%  
Cash flow per share (Unadj.) Rs39.83.1 1,275.5%  
Dividends per share (Unadj.) Rs32.000-  
Avg Dividend yield %2.20-  
Book value per share (Unadj.) Rs102.915.9 646.7%  
Shares outstanding (eoy) m169.415.07 3,341.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.60.2 3,156.6%   
Avg P/E ratio x40.68.4 481.2%  
P/CF ratio (eoy) x36.74.1 896.0%  
Price / Book Value ratio x14.20.8 1,766.8%  
Dividend payout %89.20-   
Avg Mkt Cap Rs m246,85865 381,749.7%   
No. of employees `000NANA-   
Total wages/salary Rs m5,95015 40,012.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,517269 12,093.6%  
Other income Rs m1,0073 36,209.0%   
Total revenues Rs m33,524272 12,340.4%   
Gross profit Rs m8,03320 40,428.7%  
Depreciation Rs m6588 8,079.5%   
Interest Rs m185 388.0%   
Profit before tax Rs m8,36410 85,000.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2882 104,934.9%   
Profit after tax Rs m6,0768 79,326.6%  
Gross profit margin %24.77.4 334.3%  
Effective tax rate %27.422.1 123.5%   
Net profit margin %18.72.8 655.9%  
BALANCE SHEET DATA
Current assets Rs m24,943104 23,958.0%   
Current liabilities Rs m13,26464 20,650.3%   
Net working cap to sales %35.914.8 242.2%  
Current ratio x1.91.6 116.0%  
Inventory Days Days9714 687.0%  
Debtors Days Days216937 23.1%  
Net fixed assets Rs m6,98871 9,885.0%   
Share capital Rs m1,69451 3,325.6%   
"Free" reserves Rs m15,73530 52,927.8%   
Net worth Rs m17,43081 21,608.6%   
Long term debt Rs m027 0.0%   
Total assets Rs m31,930175 18,266.8%  
Interest coverage x462.63.1 14,888.3%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.01.5 66.2%   
Return on assets %19.17.1 270.7%  
Return on equity %34.99.5 367.1%  
Return on capital %48.113.4 357.6%  
Exports to sales %00-   
Imports to sales %48.10-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m15,630NA-   
Fx inflow Rs m1,6220-   
Fx outflow Rs m15,6300-   
Net fx Rs m-14,0080-   
CASH FLOW
From Operations Rs m4,84225 19,525.2%  
From Investments Rs m8,079-13 -62,046.9%  
From Financial Activity Rs m-15,433-12 132,247.0%  
Net Cashflow Rs m-2,5120 -2,093,716.7%  

Share Holding

Indian Promoters % 0.0 26.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 11.6 0.0 -  
FIIs % 2.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 73.6 34.0%  
Shareholders   114,663 6,852 1,673.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GSK Pharma vs BERYL DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GSK Pharma vs BERYL DRUGS Share Price Performance

Period GSK Pharma BERYL DRUGS S&P BSE HEALTHCARE
1-Day 3.26% -0.98% 1.18%
1-Month -9.77% -25.48% -0.75%
1-Year 52.63% 141.20% 61.82%
3-Year CAGR 10.89% 61.60% 18.16%
5-Year CAGR 8.44% 28.53% 19.79%

* Compound Annual Growth Rate

Here are more details on the GSK Pharma share price and the BERYL DRUGS share price.

Moving on to shareholding structures...

The promoters of GSK Pharma hold a 75.0% stake in the company. In case of BERYL DRUGS the stake stands at 26.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GSK Pharma and the shareholding pattern of BERYL DRUGS.

Finally, a word on dividends...

In the most recent financial year, GSK Pharma paid a dividend of Rs 32.0 per share. This amounted to a Dividend Payout ratio of 89.2%.

BERYL DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of GSK Pharma, and the dividend history of BERYL DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.